AAAAAA
Results: 1-25/39
Authors:
Fahy, JV
Boushey, HA
Lazarus, SC
Mauger, EA
Cherniack, RM
Chinchilli, VM
Craig, TJ
Drazen, JM
Ford, JG
Fish, JE
Israel, E
Kraft, M
Lemanske, RF
Martin, RJ
McLean, D
Peters, SP
Sorkness, C
Szefler, SJ
Citation: Jv. Fahy et al., Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study, AM J R CRIT, 163(6), 2001, pp. 1470-1475
Authors:
Israel, E
Drazen, JM
Liggett, SB
Boushey, HA
Cherniack, RM
Chinchilli, VM
Cooper, DM
Fahy, JV
Fish, JE
Ford, JG
Kraft, M
Kunselman, S
Lazarus, SC
Lemanske, RF
Martin, RJ
McLean, DE
Peters, SP
Silverman, EK
Sorkness, CA
Szefler, SJ
Weiss, ST
Yandava, CN
Citation: E. Israel et al., Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma, INT A AL IM, 124(1-3), 2001, pp. 183-186
Authors:
Szefler, SJ
Citation: Sj. Szefler, A review of budesonide inhalation suspension in the treatment of pediatricasthma, PHARMACOTHE, 21(2), 2001, pp. 195-206
Authors:
Lazarus, SC
Boushey, HA
Fahy, JV
Chinchilli, VM
Lemanske, RF
Sorkness, CA
Kraft, M
Fish, JE
Peters, SP
Craig, T
Drazen, JM
Ford, JG
Israel, E
Martin, RJ
Mauger, EA
Nachman, SA
Spahn, JD
Szefler, SJ
Citation: Sc. Lazarus et al., Long-acting beta(2)-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2583-2593
Authors:
Lemanske, RF
Sorkness, CA
Mauger, EA
Lazarus, SC
Boushey, HA
Fahy, JV
Drazen, JM
Chinchilli, VM
Craig, T
Fish, JE
Ford, JG
Israel, E
Kraft, M
Martin, RJ
Nachman, SA
Peters, SP
Spahn, JD
Szefler, SJ
Citation: Rf. Lemanske et al., Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2594-2603
Authors:
Szefler, SJ
Citation: Sj. Szefler, Pharmacokinetics of intranasal corticosteroids, J ALLERG CL, 108(1), 2001, pp. S26-S31
Authors:
Szefler, SJ
Citation: Sj. Szefler, Challenges in assessing outcomes for pediatric asthma, J ALLERG CL, 107(5), 2001, pp. S456-S464
Authors:
Szefler, SJ
Weiss, S
Tonascia, J
Citation: Sj. Szefler et al., Asthma, corticosteroids, and growth. Reply, N ENG J MED, 344(8), 2001, pp. 607-608
Authors:
Leone, FT
Mauger, EA
Peters, SP
Chinchilli, VM
Fish, JE
Boushey, HA
Cherniack, RM
Drazen, JM
Fahy, JV
Ford, J
Israel, E
Lazarus, SC
Lemanske, RF
Martin, RJ
McGeady, SJ
Sorkness, C
Szefler, SJ
Citation: Ft. Leone et al., The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research, CHEST, 119(4), 2001, pp. 1027-1033
Authors:
Israel, E
Drazen, JM
Liggett, SB
Boushey, HA
Cherniack, RM
Chinchilli, VM
Cooper, DM
Fahy, JV
Fish, JE
Ford, JG
Kraft, M
Kunselman, S
Lazarus, SC
Lemanske, RF
Martin, RJ
McLean, DE
Peters, SP
Silverman, EK
Sorkness, CA
Szefler, SJ
Weiss, ST
Yandava, CN
Citation: E. Israel et al., The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma, AM J R CRIT, 162(1), 2000, pp. 75-80
Authors:
Vanden Burgt, JA
Busse, WW
Martin, RJ
Szefler, SJ
Donnell, D
Citation: Ja. Vanden Burgt et al., Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma, J ALLERG CL, 106(6), 2000, pp. 1210-1226
Authors:
Szefler, SJ
Citation: Sj. Szefler, Meeting the needs of the modernization act: Challenges in developing pediatric therapies, J ALLERG CL, 106(3), 2000, pp. S115-S117
Authors:
Szefler, SJ
Citation: Sj. Szefler, The changing faces of asthma, J ALLERG CL, 106(3), 2000, pp. S139-S143
Authors:
Skoner, DP
Szefler, SJ
Welch, M
Walton-Bowen, K
Cruz-Rivera, M
Smith, JA
Citation: Dp. Skoner et al., Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma, J ALLERG CL, 105(2), 2000, pp. 259-268
Authors:
Spahn, JD
Szefler, SJ
Citation: Jd. Spahn et Sj. Szefler, Glucocorticoid therapy in asthma, CUR CL PRAC, 2000, pp. 385-404
Authors:
Spahn, JD
Szefler, SJ
Citation: Jd. Spahn et Sj. Szefler, Inhaled glucocorticoids, LUNG BIOL H, 145, 2000, pp. 1-52
Authors:
Spahn, JD
Szefler, SJ
Citation: Jd. Spahn et Sj. Szefler, Inhaled glucocorticoids, established and new, LUNG BIOL H, 139, 2000, pp. 155-181
Authors:
Leung, DYM
Spahn, JD
Szefler, SJ
Citation: Dym. Leung et al., Immunologic basis and management of steroid-resistant asthma, ALL ASTH P, 20(1), 1999, pp. 9-14
Authors:
Kemp, JP
Skoner, DP
Szefler, SJ
Walton-Bowen, K
Cruz-Rivera, M
Smith, JA
Citation: Jp. Kemp et al., Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children, ANN ALLER A, 83(3), 1999, pp. 231-239
Authors:
Wamboldt, FS
Spahn, JD
Klinnert, MD
Wamboldt, MZ
Gavin, LA
Szefler, SJ
Leung, DYM
Citation: Fs. Wamboldt et al., Clinical outcomes of steroid-insensitive asthma, ANN ALLER A, 83(1), 1999, pp. 55-60
Authors:
Hamid, QA
Wenzel, SE
Hauk, PJ
Tsicopoulos, A
Wallaert, B
Lafitte, JJ
Chrousos, GP
Szefler, SJ
Leung, DYM
Citation: Qa. Hamid et al., Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma, AM J R CRIT, 159(5), 1999, pp. 1600-1604
Authors:
Szefler, SJ
Citation: Sj. Szefler, Corticosteroid treatment of asthma: now at the crossroads - Reply, RESP MED, 93(2), 1999, pp. 142-144
Authors:
Leung, DYM
Szefler, SJ
Citation: Dym. Leung et Sj. Szefler, Corticosteroid-insensitive asthma, IMMUNOL ALL, 19(4), 1999, pp. 837
Authors:
Szefler, SJ
Leung, DYM
Citation: Sj. Szefler et Dym. Leung, Corticosteroids in respiratory allergy - Preface, IMMUNOL ALL, 19(4), 1999, pp. XI-XII
Authors:
Szefler, SJ
Citation: Sj. Szefler, Meeting needs of infants and young children with asthma: New developments in nebulized corticosteroid therapy - Proceedings of a symposium held march13, 1998, at the 54th annual meeting of the American Academy of Allergy, Asthma, and Immunology in Washington, DC - Introduction, J ALLERG CL, 104(4), 1999, pp. S159-S161